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ttp://dx.doi.org/10.1016/j.ajpath.2013.08.007Simian virus 40 (SV40), family Polyomaviridae, in immunocompromised macaques can cause fatal
demyelinating central nervous system disease analogous to progressive multifocal leukoencephalopathy
caused by John Cunningham (JC) virus in immunocompromised humans. Recently, we have demon-
strated that JC virus can infect cerebellar granule cell neurons and cortical pyramidal neurons in
immunosuppressed people. To examine whether SV40 neuronal infection occurs spontaneously in
immunosuppressed macaques, we analyzed archival brain specimens from 20 simian immunodeﬁciency
viruseinfected rhesus with AIDS and 1 cynomolgus post-transplant selected with SV40 brain infection
from archival records from 1991 to 2012. In addition to white matter SV40 distribution in classic
demyelinating progressive multifocal leukoencephalopathy, some of the 21 monkeys exhibited
meningeal, subpial neocortical, and periventricular virus. This distribution pattern corresponded to
broader viral tropism with neuronal infection in 14 (66.7%) of 21 cases. In all 14 cases, identiﬁed
neurons were positive for early SV40 transcript large T antigen, but only 4 of the 14 cases exhibited late
viral transcript viral protein 1epositive neurons. SV40-infected neurons were detected in frontal, pa-
rietal, occipital, and temporal cortices, hippocampus, thalamus, and brain stem. These observations
conﬁrm that spontaneous SV40 neuronal infection occurs in immunosuppressed macaques, which
parallels JC viruseneuronal infection in immunosuppressed patients. Neuronal infection may be an
important aspect of both SV40 and JC virus neuropathogenesis in their respective hosts. (Am J Pathol
2013, 183: 1910e1917; http://dx.doi.org/10.1016/j.ajpath.2013.08.007)Supported by NIH grant T32 OD011064 (S.V.W.) and New England
Primate Research Center Base grant P51OD011103-51.Primate polyomaviruses include human viruses, such as
John Cunningham virus (JCV), BK virus, KI virus, WU
virus, and Merkel cell carcinoma virus, and nonhuman pri-
mate viruses, such as simian vacuolating virus 40 (SV40).1e6
SV40 was the ﬁrst primate polyomavirus to be discovered
and described in detail, and is closely related to JCV and BK
virus, polyomaviruses causing important human diseases.7
The SV40 virus was discovered as a contaminant in early
batches of polio vaccine that were produced in rhesus
monkey kidney cells.
Viral reactivation or primary infection in immunosup-
pressed animals may cause several clinical conditions with
central nervous system (CNS), pulmonary, or renal
involvement.8 Reactivation of SV40 in immunosuppressedstigative Pathology.
.rhesus monkeys can cause a demyelinating progressive
multifocal leukoencephalopathy (PML)elike illness, which
is the prototypical disease of JCV in immunosuppressed
humans. SV40 can also cause a second CNS manifestation
characterized by meningoencephalitis affecting cerebral
gray matter without demyelination, which is histologically
distinct from PML.9
Recently, we have shown that JCV causing PML in im-
munosuppressed human patients has the ability to infect
cortical and granule cell layer neurons.10e17 Experimentally,
we also demonstrated that when two SV40-negative, simian
SV40 Infection in Neurons of MacaqueHIV-immunosuppressed rhesus monkeys were inoculated
with SV40CNS1 clone, both the animals developed menin-
goencephalitis with SV40 infection of cerebral cortical
neurons and glial cells.12 In addition to this single experi-
mental study report, to our knowledge, there is no other
published report regarding SV40 infection of neurons in
rhesus macaques.
Herein, we report frequent spontaneous SV40 neuronal
infection in cortical, hippocampal, thalamic, and brain stem
neurons in immunosuppressed macaques. SV40-associated
CNS disease in these animals recapitulates JCV-associated
classic PML lesions, with some unique presentations affecting
periventricular and subpial cortical areas. To our knowledge,
this is the ﬁrst description of spontaneously occurring SV40
neuronal infection in immunosuppressed macaques.
Materials and Methods
Animals
Cases for this study were selected from a database of nec-
ropsy records at the New England Primate Research Center
(NEPRC) from 1996 to 2012. A total of 1324 records of
simian immunodeﬁciency virus (SIV)einfected macaques
were examined, and cases were identiﬁed and selected for
further analysis based on prior identiﬁcation of SV40-
associated disease, including PML-like CNS disease and
SV40-associated nephritis. SV40 cases in rhesus macaque
(Macaca mulatta) were SIV infected with end-stage simian
AIDS, deﬁned by the presence of opportunistic infections
or other AIDS-deﬁning lesions. Cynomolgus macaques
(Macaca fascicularis) selected for the study included those
with SV40 CNS and/or renal infection associated with
immunosuppressive drug regimens after kidney trans-
plantation. In addition, three rhesus macaques previously
studied from 1990 to 1991 were also included in this cohort
for further analysis.18
The animals described herein were maintained in accor-
dance with the guidelines of the Institutional Animal Care
and Use Committee of Harvard Medical School (South-
borough, MA), and were housed at the NEPRC, Harvard
Medical School, and cared for by its veterinary staff.
Single and Double IHC
Immunoperoxidase staining for SV40 alone was performed
on formalin-ﬁxed, parafﬁn-embedded (FFPE) sections (6
mm thick) with the use of standard avidin-biotin peroxidase
complex technique (Dako, Carpentaria, CA). In brief, the
sections were deparafﬁnized and rehydrated. Endogenous
peroxidase activity was quenched with 3% hydrogen
peroxide for 5 minutes, followed by antigen retrieval ach-
ieved by microwaving for 20 minutes in citrate buffer. The
sections were treated with Dako Protein Block for 10 mi-
nutes and incubated overnight at 4C with a speciﬁc anti-
SV40 large T antigen (T-Ag; IgG1, 1:25,600 dilution;The American Journal of Pathology - ajp.amjpathol.orgOncogene, La Jolla, CA), which does not cross-react with
small T-Ag, or for 1 hour at room temperature with mouse
monoclonal anti-SV40 VP1 (PAB597, 1:1000; generous gift
from Dr. Walter Atwood, Brown University, Providence,
RI).19 Slideswere then incubatedwith the secondary antibody
(biotinylated horse anti-mouse, 1:200; Vector, Burlingame,
CA) for 30 minutes, followed by 30 minutes’ incubation with
Vectastain ABC Elite (Vector). Tissue sections were washed
and developed with 3,30-diaminobenzidine chromagen
(Dako) and counterstained with Mayer’s hematoxylin.
Isotype-matched irrelevant controls were tested on all tissues.
For double-label immunohistochemistry (IHC), after pri-
mary SV40 antibody development, the slides were blocked
for 30 minutes with universal block (Dako) and then by
mouseeon-mouse block, as per the manufacturer’s recom-
mendation (Vector). Slides were then incubated with the
monoclonal neuron-speciﬁc microtubule-associated protein
2 (MAP2) antibody (HM-2, M-4403, 1:400 dilution; Sigma,
St. Louis, MO) for 1 hour at room temperature, and vector
red chromogen was used for stain development.
ISH for SV40 DNA
The FFPE slides were deparafﬁnized, rehydrated, and un-
derwent antigen retrieval in protein K solution for 10 minutes
at 37C. Sections were then immersed in PBS containing
0.1 mol/L glycine for 5 minutes at room temperature, rinsed
in 1 PBS, and then incubated for 10 minutes in 0.1 mol/L
triethanolamine/0.25% acetic anhydride, followed by a 2-
minute incubation in 2 standard saline citrate. The sections
were then incubated for 15 minutes in 100 mmol/L Tris/0.1
mol/L glycine, followed by a 2-minute incubation with 2
standard saline citrate. The tissue sections were incubated
with 100 mL of hybridization mixtures containing 0.25 ng/
mL biotinylated SV40 DNA probes (Enzo Life Sciences,
Farmingdale, NY), combined with mRNA hybridization
buffer, and covered with a plastic coverslip (HybriSlip;
Sigma-Aldrich, St. Louis, MO). The slides were incubated
on a 95C hot plate for 5 minutes to denature the tissue DNA,
and then incubated in the 37C oven overnight. The tissue
sections were washed and incubated with alkaline phos-
phataseeconjugated streptavidin at 1:1000 dilutions for 20
minutes at room temperature. Detection of hybridized probes
was done using 5-bromo-4-chloro-indolylphosphate/nitro-
blue tetrazolium (Roche, Indianapolis, IN) as a chromogenic
substrate for 60 minutes. Sections were counterstained with
nuclear fast red, dehydrated in a graded ethanol series, and
coverslipped with Eukitt mounting medium (Electron
Microscopic Sciences, Washington, PA). Negative controls
included noninfected tissues and omission of the DNA
probe.
Electron Microscopy
To determine whether SV40 viral particles were present in
neurons, speciﬁc sections of the affected brains were selected1911
Kaliyaperumal et alfor neurons double labeled with SV40 large T-Ag and
MAP2. Brain regions encompassing large T-Ageexpressing
MAP2þ neurons were embedded on the slide in Eponate 12
resin (Ted Pella, Inc., Redding, CA), for electron micro-
scopy. The sections were removed from the slide, and the
desired areas were chosen by light microscopy. Sections were
cut on a Leica Ultra Cut R microtome, stained with uranyl
acetate and Sato’s lead stain,20 and examined on a JEOL
electron microscope (Joel USA, Peabody, MA).
Quantitation of SV40-Infected Glial Cells and Neurons
Immunopositive cells for large T-Ag and VP1 were indi-
vidually counted from a minimum of four microscope ﬁelds
at 20 magniﬁcation. Quantitation of SV40-infected neu-







1 PML Mm NEPRC 1976
2 PML Mm NEPRC 1820
3 PML Mm Tulane (Covington, LA) 2876
4 PML Mm NEPRC 871
5 PML Mm Covance (Kalamazoo, MI) 1424
6 PML Mm Hazelton Research (Alice, TX) NA
7 Focal PML Mm Harlan (Indianapolis, IN) 631
8 PML, ME Mm CPRC (Sabana Seca, Puerto Rico) 445
9 PML, ME Mm Primate Imports (Miami, FL) NA
10 PML, ME Mm Mason Research Labs (Utica, NY) 752
11 PML, ME Mm NEPRC 429
12 ME Mm CPRC 227
13 Encephalitis Mm NEPRC 347
14 Encephalitis Mm NEPRC 339
15 PML Mm NEPRC 442
16 PML, ME Mm CPRC 214
17 Encephalitis Mm NEPRC 654
18 Meningitis Mm Mason Research Labs 1000
19 Encephalitis Mm NEPRC 35
20 Encephalitis Mm CPRC 571
21 Meningitis Mf Labs of Virginia
(Newport News, VA)
115
22 Nephritis Mm Lab Animal Breeders
(Immokalee, FL)
606
23 Nephritis Mm NEPRC 231
24 Nephritis Mm NEPRC 111
25 Nephritis Mm Michigan Biologic Products
(Ann Arbor, MI)
672
26 Nephritis Mm NEPRC 771
27 Nephritis Mm NEPRC 183
28 Nephritis Mf Labs of Virginia NA
29 Nephritis Mf Labs of Virginia NA
30 Nephritis Mf Labs of Virginia NA
The severity of brain lesions was scored on a scale of 0 to 3 (0, none; 1, low;
CRPC, Caribbean Primate Research Center; dpi, days post inoculation with SIV;
not available; ND, not determined; NEPRC, New England Primate Research Center
1912directed at the large T-Ag or VP1 and neuron-speciﬁc
MAP2. Brieﬂy, a minimum of four 20 ﬁelds per slide were
counted for either T-Age or VP1-positive cells for single
IHC and T-Agþ MAP2þ or VP1þ MAP2þ cells for double
IHC. Nuclei in each ﬁeld (ranging from 400 to 900) were
counted to serve as the denominator of total nucleated cells.
SV40-immunopositive cells were expressed as a percentage
of all cells in the ﬁeld. For each speciﬁc region (cortical gray
matter, hippocampus, and white matter/gray matter junc-
tions), a total of 200 SV40-positive cells were counted and
the frequency of infected neurons was expressed as a per-
centage of all SV40-infected cells in those regions for each
case. To assess the frequency of neuronal infection, ﬁelds
with SV40þ MAP2þ neurons were counted, with a mini-
mum of 200 MAP2þ neurons, and calculated as a percent-

















Yes Yes No Yes 3 No
Yes Yes No Yes 3 No
Yes Yes No No 2 No
Yes Yes No Yes 2 No
Yes Yes No Yes 3 No
Yes Yes No No 3 Yes
Yes Yes No No 1 No
Yes Yes Yes No 3 Yes
Yes Yes Yes No 3 No
Yes Yes Yes Yes 3 No
Yes Yes Yes No 3 Yes
Yes No Yes Yes 3 Yes
Yes No No No 3 No
Yes No No No 2 No
No Yes No No 2 No
No Yes Yes No 3 Yes
No No No No 1 NA
No No Yes Yes 1 No
No No No No 0 Yes
No No No No 1 No
No No Yes No 1 Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
No No No No ND Yes
2, medium; and 3, severe).
ME, meningoencephalitis; Mf, Macaca fascicularis; Mm, Macaca mulatta; NA,
.
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SV40 Infection in Neurons of MacaqueStatistical Analysis and Graphical Presentation
A nonparametric Mann-Whitney t-test was used to deter-
mine the statistical differences between T-Ag and VP1
staining of the same brain region within the same animal.
Data from analysis of infected cells were plotted on a bar
graph using GraphPad Prism software version 5 (GraphPad
Software Inc., San Diego, CA).Figure 1 Clinical and survival data. A: A higher percentage of animals
with neuronal SV40 infection or demyelination developed neurological
symptoms compared with those without neuronal infection or demyelin-
ation. B: SV40-infected macaques with demyelination survived longer after
SIV inoculation compared with animals or demyelination. *P Z 0.0432.
The trend toward longer disease course and survival in macaques with
neuronal infection did not reach signiﬁcance. dpi, days post inoculation
with SIV.Results
Macaque SV40 Study Cohort
Of 1324 SIV-infected animals examined, 30 macaques
(2.3%), including 26 rhesus and 4 cynomolgus macaques,
were identiﬁed as having active SV40 infection detected by
histopathological examination of tissues. The 26 rhesus ma-
caques were immunosuppressed by SIV and euthanized
because of either neurological signs or other simian
AIDSerelated conditions from a total of 294 cases with
simian AIDS (8.8%). The cynomolgus macaques (n Z 4)
were immunosuppressed with a drug regimen to reduce
rejection of renal transplants. Of the 30 monkeys in this study,
13 (43.3%) originated from NEPRC, with the remainder from
other primate centers and facilities [17 (56.7%)]. Twenty
rhesus macaques (11 males and 9 females) and one male
cynomolgus, ranging in age from 1.6 to 12 years (median, 5.7
years), had SV40 infection in the brain (21/30, 70%)
(Table 1). The other nine macaques were cases of exclusive
SV40 nephritis. Of the 21 animals with SV40CNS disease, 14
(67%) had SV40þ neurons. Of the 21 animals with SV40
CNS disease, 7 (33.3%) exhibited clinical neurological signs
at terminal disease, with 6 (42.9%) of 14 and 5 (38.5%) of 13
of those classiﬁed histologically with neuronal infection and
demyelination, respectively (Table 1 and Figure 1A).
Although there was a trend toward longer survival in ma-
caques classiﬁed with SV40 neuronal infection, there was
signiﬁcantly longer survival in those with demyelination
(mean, 1080 days; median, 752 days) compared with those
without demyelination (mean, 453 days; median, 347 days;
PZ 0.04) (Figure 1B). Assessed another way, those animals
that survived longer than 1 year (10/13, 76.9%) were more
likely to have developed demyelination.
In the animals with demyelination, there was a higher
likelihood to have SV40 neuronal infection (11/13, 84.6%)
(Table 1), whereas cases without signiﬁcant demyelination
were less likely to have neuronal infection (3/8, 37.5%)
(Table 1). Eight cases exhibited SV40 infection of the
meninges (8/21, 38%) characterized by diffuse meningeal
expansion by lymphocytic inﬁltration (Figure 2G). Only 4
(19%) of the 21 SV40 CNS cases exhibited prominent
perivascular lymphocytic cuffs (Figure 2), which were
interestingly devoid of SV40-infected cells (Figure 2E).
Four cases (19%) also had SV40 inclusions in other brain
regions, including the cerebellum, brain stem, and spinal
cord.The American Journal of Pathology - ajp.amjpathol.orgThe lesions associated with SV40 CNS disease were
classiﬁed with one or more of the following histological
patterns, summarized in Table 1: i) PML, which includes
signiﬁcant demyelination (13/21, 62%), ii) PML with
meningoencephalitis (5/21, 23.8%), iii) encephalitis/menin-
goencephalitis without demyelination (6/21, 28.5%), and iv)
meningitis (2/21, 9.5%). Moderate to severe demyelination
and necrosis were assessed by loss of myelin by either
routine H&E or Luxol fast blue (LFB) stain (Figure 2)
within white matter regions (WMs) (Figure 2C), at the gray-
white matter junction (GWMJ) (Figure 2, F and I), or in the
periventricular zone (Figure 2L).
Distribution and Quantitation of SV40 in the Brain
To analyze the tissue distribution of viral infection in the
brain, SV40þ cells were further categorized based on four
distinct patterns assessed by H&E staining, SV40 in situ
hybridization (ISH), and LFB staining: i) infected cells in
WM (Figure 2, AeC), ii) gray matter (GM) or GWMJ
(Figure 2, DeF), iii) meninges and subpial layer (Figure 2,
GeI), or iv) in the periventricular or subventricular zone
(Figure 2, JeL). Observed patterns of virus suggest two
different routes of viral spread within the neuron-rich re-
gions of the brain: expansion from the white matter or ex-
tension from the meninges. Animals with large white matter
lesions frequently exhibited demyelination that extended
across the gray-white matter junction into the deep cortical
layers with a leading edge of infected cells at the periphery
of the lesions (Figure 2E). Virus distribution in other ani-
mals appeared to originate from the meninges extending
into the superﬁcial gray matter (Figure 2H).
To determine the overall frequency of SV40 infection,
detected by expression of either large T-Ag or VP1 in all
CNS cases, infected cells were counted and normalized to the
total count of nuclei in the same ﬁeld. The frequency of
infection, shown as percentage of infected cells per 400 to1913
Figure 3 Quantitative analysis of SV40-infected cells in the cortex and
subcortical areas of cerebrum. A: Overall expression frequency of SV40 large
T-Ag and viral protein 1 (VP1) in all cases, depicted as percentage of SV40-
infected cells based on total nuclei counted in four nonoverlapping regions
in GM and four in WM combined. B: Trend toward higher expression of SV40
large T-Ag and VP1 in WM regions compared with GM regions in all cases,
represented as percentage of infected cells expressing either SV40 T-Ag or
VP1 over all counted cells within regions examined (mean % with SEM). C:
Trend toward higher expression of SV40 large T-Ag and VP1 in cases with
neuronal infection. D: In cases with neuronal infection, the frequency of
SV40þ cells that were MAP2þ neurons as a percentage of all SV40-infected
cells analyzed in at least four 20 ﬁelds is highly variable. E: There is a
signiﬁcantly higher frequency of detectable neuronal expression of SV40
large T-Ag compared with VP1. *P < 0.001.
Figure 2 SV40 lesion distribution in the brain demonstrated by H&E (A,
D, G, and J), ISH (B, E, H, and K), and LFB for myelin (C, F, I, and L). SV40-
infected cells and associated necrosis and demyelination were observed in
the white matter (AeC), across the gray-white matter junction (DeF),
within the meninges extending into the superﬁcial cortical layers (GeI), and
around ventricles in the subventricular zone (JeL). Higher-magniﬁcation
images of SV40-infected cells in H&E, ISH, or LFB (insets, AeC and E).
Original magniﬁcation, 60. LV, left ventricle; WM, white matter.
Kaliyaperumal et al900 total nuclei per brain region examined, varied con-
siderably, ranging from 1% to 16% of all cells counted
(Figure 3A). To assess any difference in frequency of
infection within GM or WM, SV40-immunopositive cells
were counted in multiple ﬁelds from GM and WM and were
analyzed together for all 21 CNS cases and then for neuronal
and nonneuronal cases. The data showed a trend in all CNS
cases toward higher expression of SV40 large T-Ag and VP1
in WM regions (Figure 3B) and a trend toward higher overall
frequency of infection in cases with neuronal infection
compared with those without neuronal infection (Figure 3C).
SV40þ MAP2þ Infected Neurons
Double-label IHC for SV40 viral proteins and neuron-
speciﬁc MAP2 demonstrated that subpopulations of neurons
in cerebral cortex, hippocampus, thalamus, and brain stem
were infected (Figure 4). The extent of neuronal infection in
different brain regions and between animals was variable
(Figure 3D and Figure 4). In some cases, neuronal infection
was frequent within a region, such as the hippocampus
(Figure 4, B and EeG), whereas in the other regions it was
more limited (Figure 4, C, D, and H).
To assess differences in expression of large T-Ag and VP1
in MAP2þ neurons, double-labeled neurons were counted in
at least four 20 ﬁelds containing 150 to 200 neurons, and1914examined as a percentage of all of the SV40-infected cells in
the same ﬁeld. These data show that the frequency of
expression of large T-Ag and VP1 in infected neurons is
highly variable (Figure 3D), and that there is a higher fre-
quency of detectable neuronal expression of SV40 large T-
Ag compared with VP1 (P < 0.001) (Figure 3E). Although
all 14 cases with infected neurons expressed detectable large
T-Ag, only 4 of the 14 cases exhibited rare neurons with VP1
expression (4/14, 29%). The overall frequency of neuronal
infection based on expression of large T-Ag ranged from 5%
to 25% of neurons in the infected regions examined.
Visualization of SV40 Virions in Neurons by Electron
Microscopy
Ultrastructural examination of SV40þ cortical neurons in
one of the cases conﬁrmed the presence of virus particles inajp.amjpathol.org - The American Journal of Pathology
Figure 4 ISH and double-label IHC images of SV40-infected neurons in
the cortical and subcortical areas of the cerebrum. A: Whole slide scan
depicting in situelabeled SV40-infected cells. B: In situelabeled SV40-
infected hippocampal neurons. Double-labeled IHC with neuron-speciﬁc
MAP2 (reddish pink) and SV40 large T antigen (brown) depicts SV40-
infected neurons in the pyramidal layer of the parietal cortex (C and E),
thalamus (D), hippocampus (F and G), and brain stem (H). The arrowheads
indicate SV40 infected neurons.
SV40 Infection in Neurons of Macaqueneurons. Polyomavirus virions (size, 40 nm) were visualized
uniformly within the nuclei of cells with morphological and
ultrastructural elements consistent with neurons, including
a large nucleus with a central nucleolus, nuclear pores,
frequent mitochondria, and the absence of astrocyte-speciﬁc
intermediate ﬁlaments (Figure 5). Intranuclear inclusions
were composed of numerous virions arranged in para-
crystalline array and electron-dense aggregates of clumped
chromatin scattered throughout the nucleus and along the
inner surface of the nuclear membrane. Some virions also
were located just outside of the nuclear membrane in the
cytoplasm.Figure 5 Transmission electron micrograph of a neuron infected with
SV40 virus. The nucleus at bottom right contains abundant intranuclear
SV40 polyomaviral particles (diameter, 40 nm) (white arrowheads and
inset). Original magniﬁcations: 10,000 (main image); 20,000 (inset).
Neuronal ultrastructural features include large nucleus with central nucle-
olus, nuclear pores, abundant mitochondria, myelinated axosomatic syn-
apses, and absence of intermediate ﬁlaments.Peripheral Tissue Reservoirs of SV40
Collected samples of lymph nodes, spleen, kidney, liver,
bone marrow, lung, and intestines were screened by IHC for
the presence of large T-Age or VP1-expressing cells.The American Journal of Pathology - ajp.amjpathol.orgSV40-positive inclusions in kidney were detected in the
renal tubular epithelial cells of 15 (50%) of 30 cases,
including 7 (33%) of 21 cases with SV40 CNS infection
(Table 1 and Supplemental Figure S1A). Of the 30 cases, 3
(10%) had SV40 inclusions in the lung, 2 (6.7%) had SV40
in the liver, 1 (3.3%) had SV40 in the retinal ganglion cells,
and 1 (3.3%) expressed SV40 large T-Agepositive, but
VP1-negative, cells in smooth muscle of the small intestine
(Supplemental Figure S1B).
Discussion
We report herein that approximately 60% of immuno-
compromised macaques with SV40 CNS disease develop
neuronal infection, suggesting that this is a signiﬁcant
and previously underappreciated aspect of SV40 patho-
genesis. Reactivation of latent SV40 has been observed
in 2.6% of SIV-infected monkeys, and this is associated
with a disease that resembles PML.9 In our study cohort,
more than half of the SV40 CNS-infected animals had
classic PML-like lesions within white matter regions,
occasionally crossing the GWMJ extending into the GM
regions, as has been described in JCV-associated human
PML.17,21 In addition, several of the animals developed1915
Kaliyaperumal et aldemyelination within the periventricular or subven-
tricular zone, which has not been previously reported.
Macaques with classic PML lesions frequently exhibited
neurological symptoms due to extensive white matter
demyelination.
Our observations support the notion that neuronal in-
fection may be more frequent than previously recognized
in patients with JCV CNS disease.11,12,15e17 The fre-
quency at which neurons are infected by SV40 virus varied
from 5% to 25% of all CNS infected cells, suggesting that
neuronal infection is a signiﬁcant component of poly-
omavirus pathogenesis in the brain. Higher neuronal
expression of SV40 large T-Ag than VP1 may represent
non-productive infection of some neurons; however, this
observation may reﬂect VP1 antigenic variability in aged
parafﬁn-embedded tissues. The trend toward higher fre-
quency of infected cells in the CNS of cases with neuronal
infection suggests that neuronal infection may be a con-
sequence of higher brain virus burden. This may be a
reﬂection of a longer disease course and survival seen in
the neuronal cases.
Based on the patterns of detectable virus in the cerebrum,
there may be at least two means of virus spread to neuron-
rich areas in the cortex to allow for SV40 neuronal infection.
First, the virus extends from the initial white matter lesions,
across the gray-white matter junction, and into the cortical
gray matter. The second observed route is that SV40 infects
the meninges and extends into the subpial superﬁcial cortex.
Interestingly, infected cells were rarely associated with
vessels in either the white matter regions or the meninges. If
SV40 does, however, enter the CNS through the vascula-
ture, other factors, including the viral strain, coincident in-
ﬂammation in the CNS, and alterations to blood-brain
barrier permeability, may inﬂuence the route of entry into
the CNS.
The reservoir tissues and recrudescence of SV40 are not
clearly understood, but there is evidence in humans that
JCV remains dormant in lymphoid organs, bone marrow,
kidney, and the brain itself (in some individuals).22e27 In
this study cohort, approximately a third of the animals with
CNS disease had detectable SV40-immunopositive cells in
the kidney, but none in lymphoid tissues or bone marrow.
One animal had SV40-positive cells in the intestinal smooth
muscle. Because of limited access to frozen tissues and to
historical serum samples from this cohort, we were unable
to conduct extensive PCR analysis of tissue viral reservoirs
or to ascertain which cases might have represented primary
infections versus reactivation, as had been demonstrated by
Simon et al.9 These would both be interesting studies to
pursue with future cases.
Finally, this study sheds new light on polyomavirus in-
fection and neuropathogenesis in the CNS. Both JCV and
SV40 exhibit potential for neuronal infection. SV40-
infected neurons were detected in parietal, occipital, and
temporal cortices, hippocampus and dentate gyrus, thal-
amus, and brain stem. We also describe subventricular1916lesions with demyelination and necrosis. Further investiga-
tion into the determinants of SV40 and JCV neuronal
infection is warranted.Acknowledgments
We thank Dr. Ron Desrosiers for availability to archive
tissue and informative discussions and Kristen Toohey for
graphic assistance.Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2013.08.007.References
1. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G,
Persson MA, Dalianis T, Ramqvist T, Andersson B: Identiﬁcation of a
third human polyomavirus. J Virol 2007, 81:4130e4136
2. Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a pol-
yomavirus in human Merkel cell carcinoma. Science 2008, 319:
1096e1100
3. Gardner SD, Field AM, Coleman DV, Hulme B: New human papo-
vavirus (B.K.) isolated from urine after renal transplantation. Lancet
1971, 1:1253e1257
4. Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB,
Wu G, Brennan DC, Storch GA, Sloots TP, Wang D: Identiﬁcation of
a novel polyomavirus from patients with acute respiratory tract in-
fections. PLoS Pathog 2007, 3:e64
5. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH:
Cultivation of papova-like virus from human brain with progressive
multifocal leucoencephalopathy. Lancet 1971, 1:1257e1260
6. White MK, Safak M, Khalili K: Regulation of gene expression in
primate polyomaviruses. J Virol 2009, 83:10846e10856
7. Sweet BH, Hilleman MR: The vacuolating virus, SV 40. Proc Soc Exp
Biol Med 1960, 105:420e427
8. Horvath CJ, Simon MA, Bergsagel DJ, Pauley DR, King NW,
Garcea RL, Ringler DJ: Simian virus 40-induced disease in rhesus
monkeys with simian acquired immunodeﬁciency syndrome. Am J
Pathol 1992, 140:1431e1440
9. Simon MA, Ilyinskii PO, Baskin GB, Knight HY, Pauley DR,
Lackner AA: Association of simian virus 40 with a central nervous
system lesion distinct from progressive multifocal leukoencephalop-
athy in macaques with AIDS. Am J Pathol 1999, 154:437e446
10. Dang X, Koralnik IJ: A granule cell neuron-associated JC virus variant
has a unique deletion in the VP1 gene. J Gen Virol 2006, 87:2533e2537
11. Dang X, Vidal JE, Penalva de Oliveira AC, Simpson DM, Morgello S,
Hecht JH, Ngo LH, Koralnik IJ: JC virus granule cell neuronopathy is
associatedwithVP1C terminusmutants. J GenVirol 2012, 93:175e183
12. Dang X, Wuthrich C, Axthelm MK, Koralnik IJ: Productive simian
virus 40 infection of neurons in immunosuppressed Rhesus monkeys. J
Neuropathol Exp Neurol 2008, 67:784e792
13. Du Pasquier RA, Corey S, Margolin DH, Williams K, Pﬁster LA, De
Girolami U, Mac Key JJ, Wuthrich C, Joseph JT, Koralnik IJ: Pro-
ductive infection of cerebellar granule cell neurons by JC virus in an
HIVþ individual. Neurology 2003, 61:775e782
14. Koralnik IJ, Wuthrich C, Dang X, Rottnek M, Gurtman A, Simpson D,
Morgello S: JC virus granule cell neuronopathy: a novel clinical
syndrome distinct from progressive multifocal leukoencephalopathy.
Ann Neurol 2005, 57:576e580ajp.amjpathol.org - The American Journal of Pathology
SV40 Infection in Neurons of Macaque15. Wuthrich C, Cheng YM, Joseph JT, Kesari S, Beckwith C, Stopa E,
Bell JE, Koralnik IJ: Frequent infection of cerebellar granule cell
neurons by polyomavirus JC in progressive multifocal leukoence-
phalopathy. J Neuropathol Exp Neurol 2009, 68:15e25
16. Wuthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A,
Anderson MP, Ropper AH, Viscidi RP, Koralnik IJ: Fulminant JC
virus encephalopathy with productive infection of cortical pyramidal
neurons. Ann Neurol 2009, 65:742e748
17. Wuthrich C, Koralnik IJ: Frequent infection of cortical neurons by JC
virus in patients with progressive multifocal leukoencephalopathy.
J Neuropathol Exp Neurol 2012, 71:54e65
18. Ilyinskii PO, Daniel MD, Horvath CJ, Desrosiers RC: Genetic analysis
of simian virus 40 from brains and kidneys of macaque monkeys.
J Virol 1992, 66:6353e6360
19. Ashok A, Atwood WJ: Contrasting roles of endosomal pH and the
cytoskeleton in infection of human glial cells by JC virus and simian
virus 40. J Virol 2003, 77:1347e1356
20. Sato T: A modiﬁed method for lead staining of thin sections. J Electron
Microsc (Tokyo) 1968, 17:158e159
21. Tan CS, Koralnik IJ: Progressive multifocal leukoencephalopathy and
other disorders caused by JC virus: clinical features and pathogenesis.
Lancet Neurol 2011, 9:425e437The American Journal of Pathology - ajp.amjpathol.org22. Monaco MC, Jensen PN, Hou J, Durham LC, Major EO: Detection of
JC virus DNA in human tonsil tissue: evidence for site of initial viral
infection. J Virol 1998, 72:9918e9923
23. Randhawa PS: Anti-BK virus activity of ciproﬂoxacin and related
antibiotics. Clin Infect Dis 2005, 41:1366e1367. author reply
1367
24. Tan CS, Dezube BJ, Bhargava P, Autissier P, Wuthrich C, Miller J,
Koralnik IJ: Detection of JC virus DNA and proteins in the bone
marrow of HIV-positive and HIV-negative patients: implications for
viral latency and neurotropic transformation. J Infect Dis 2009, 199:
881e888
25. Tan CS, Ellis LC, Wuthrich C, Ngo L, Broge TA Jr., Saint-Aubyn J,
Miller JS, Koralnik IJ: JC virus latency in the brain and extraneural
organs of patients with and without progressive multifocal leu-
koencephalopathy. J Virol 2010, 84:9200e9209
26. Tang WJ, Berger SL, Triezenberg SJ, Folk WR: Nucleotides in the
polyomavirus enhancer that control viral transcription and DNA
replication. Mol Cell Biol 1987, 7:1681e1690
27. Bayliss J, Karasoulos T, McLean CA: Frequency and large T (LT)
sequence of JC polyomavirus DNA in oligodendrocytes, astrocytes
and granular cells in non-PML brain. Brain Pathol 2012, 22:
329e3361917
